113.72
Transmedics Group Inc 주식(TMDX)의 최신 뉴스
TransMedics (TMDX) Faces Downward Pressure Amid Insider Selling and Market Concerns - GuruFocus
TransMedics Extends Decline as Selling Pressure Builds - GuruFocus
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
TransMedics Group (NASDAQ:TMDX) Trading Down 7.4%What's Next? - MarketBeat
Why TransMedics Group Stock Is Sliding Today - TipRanks
TransMedics Group Q4 2025 earnings preview - MSN
17,165 Shares in TransMedics Group, Inc. $TMDX Acquired by Kensington Investment Counsel LLC - MarketBeat
Q4 2025 Transmedics Group Inc Earnings Call Transcript - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Investors to Inquire about Securities Investigation - ACCESS Newswire
TransMedics Group, Inc. $TMDX Shares Bought by Fred Alger Management LLC - MarketBeat
Cowen Maintains Buy on TransMedics Group, Inc. (TMDX) March 2026 - Meyka
Aug Mood: Can TransMedics Group Inc expand its profit margins2026 Closing Moves & Verified Momentum Stock Watchlist - baoquankhu1.vn
Oppenheimer Raises Price Target for TransMedics Group (TMDX) to - GuruFocus
TransMedics Group, Inc. Trade Ideas — LS:A2PH5P - TradingView
Lovell, TransMedics director, sells $178k in TMDX stock By Investing.com - Investing.com Nigeria
TransMedics Group stock (ISIN: US89366D3075): FDA liver tailwind, kidney upside and European push re - AD HOC NEWS
TransMedics at Oppenheimer Conference: Strategic Expansion Unveiled By Investing.com - Investing.com South Africa
TransMedics at Oppenheimer Conference: Strategic Expansion Unveiled - Investing.com
TMDX: Pursuing deeper U.S. integration, expanding in Europe, and advancing major clinical trials - TradingView
TD Cowen reiterates TransMedics stock Buy rating on liver approval - Investing.com
TransMedics: Rapidly Scaling Business Nears Free Cash Flow Breakeven (NASDAQ:TMDX) - Seeking Alpha
Is TransMedics Group, Inc. (TMDX) A Good Stock To Buy Now? - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Investors to Reach Out - ACCESS Newswire
Analysts raise TransMedics Group, Inc. (TMDX) price targets after Q4 results - MSN
TransMedics Group, Inc. $TMDX Holdings Lifted by Braidwell LP - MarketBeat
TransMedics Group Stock (ISIN: US89366D3075) Surges on Strong 2026 Outlook and Kidney Expansion Plan - AD HOC NEWS
Kidney Expansion And Strong Outlook Might Change The Case For Investing In TransMedics Group (TMDX) - simplywall.st
TransMedics group CFO Hernandez sells shares worth $1.12 million - Investing.com Nigeria
Portolan Capital Management LLC Acquires New Stake in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics (TMDX) officer Matthew Forsyth files initial Form 3 ownership - Stock Titan
Assessing TransMedics Group (TMDX) Valuation After Recent Share Price Pullback - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Reach Out - ACCESS Newswire
2026-03-12 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Reach Out | NDAQ:TMDX | Press Release - Stockhouse
Analysts Raise TransMedics Group, Inc. (TMDX) Price Targets After Q4 Results - Insider Monkey
Blair William & Co. IL Lowers Stake in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics group CFO Hernandez sells shares worth $1.12 million By Investing.com - Investing.com Nigeria
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Connect - ACCESS Newswire
(TMDX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Fieldview Capital Management LLC Acquires New Position in TransMedics Group, Inc. $TMDX - MarketBeat
Got $5,000? TransMedics Could Be a High‑Tech Organ Transplant Moonshot - AOL.com
12 Best Under-the-Radar Stocks to Buy According to Hedge Funds - Insider Monkey
TransMedics: Trials Should Broaden OCS Adoption, Watch For Headwinds (Downgrade) (TMDX) - Seeking Alpha
TransMedics Group (TMDX) Analyst Ratings Update: Stifel Raises P - GuruFocus
TransMedics: Numb Reaction To Extraordinary Fundamentals (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group (NASDAQ:TMDX) Price Target Raised to $130.00 - MarketBeat
Stifel raises TransMedics stock price target to $130 on liver strength - Investing.com
Assessing TransMedics Group (TMDX) Valuation After Recent Short Term Share Price Weakness - Yahoo Finance
TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026? - The Motley Fool
TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026? - The Motley Fool
4 Top Stocks Long-Term Investors Should Buy in March - The Globe and Mail
Weill David sells TransMedics (TMDX) shares worth $524,294 - Investing.com
Weill David sells TransMedics (TMDX) shares worth $524,294 By Investing.com - Investing.com India
자본화:
|
볼륨(24시간):